Skip to content

Ecnoglutide

Also called XW003

CAMP-biased long-acting GLP-1 analog.

  • TypePeptide
  • FormInjectable
  • Researched forMetabolic & Fat Loss
Join Skool for the protocol

No partner carries Ecnoglutide yet.

The short version

  • Why people research itFat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
  • What the evidence isPhase 3 in China, developed by Sciwind.
  • What to watchPersistent vomiting.

How Ecnoglutide works

This is the one compound in the cohort whose defining number is published, and it is not a receptor selectivity ratio — it is a signaling bias ratio, which is a different and much stranger thing.

In receptor assays, ecnoglutide induced cAMP with an EC50 of 0.018 nM and induced GLP-1 receptor internalization with an EC50 greater than 10 µM Guo 2023. Put those two numbers on the same scale: 0.018 nanomolar against more than 10 micromolar is a separation of more than 500,000-fold between the two things this receptor can be made to do. That is not a tweak.

  • Injectable

On the goal map: Appetite & satiety signaling (Lose fat)

Where to get Ecnoglutide

No partner carries it yet.

When a vetted partner does, the link and code go here.

Research on Ecnoglutide6 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Human clinical evidence

  • Phase 3 in China, developed by Sciwind.

  • The trials are Chinese-population, and that changes how the percentages read — lower baseline BMI and different body composition make direct comparison with Western obesity trials unreliable in both directions.

Correlative data

  • No Western approval and no independent real-world record. GI tolerability in the trials looks class-typical.

  • It does appear in the research-chemical market, which is worth naming: what is sold there is not the trial material.

How the mechanism reads

  • A GLP-1 analog engineered as a cAMP-biased agonist — it preferentially activates the cAMP signaling arm of the receptor while recruiting less β-arrestin.

    Mechanistic
  • Biased agonism is the interesting idea here. β-arrestin recruitment drives receptor internalization and desensitization, so a cAMP-biased agent should keep the receptor available longer. Whether that translates into a clinically distinguishable advantage is still an open question across the whole GPCR field, not just this drug.

    Mechanistic

Sources

  • Guo W, et al. Discovery of ecnoglutide - a novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog. Molecular Metabolism 2023 · PMID 37364710
  • Zhu D, et al. Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial. Nature Communications 2024 · PMID 39333121
  • Ji L, et al. Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes and Endocrinology 2025 · PMID 40555243
  • He Y, et al. Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial. Lancet Diabetes and Endocrinology 2025 · PMID 40854315
  • Shirley M. Ecnoglutide: First Approvals. Drugs 2026 · PMID 42412371
  • Li F, et al. Effect of a Novel GLP-1 Analogue Ecnoglutide on the Pharmacokinetics of Rosuvastatin and Digoxin in Healthy Participants. Diabetes, Obesity and Metabolism 2026 · PMID 42310888
  • He L, et al. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Internal Medicine 2022 · PMID 35344001
  • Stefanakis K, et al. The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation. Metabolism 2024 · PMID 39481534
  • Sattar N, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes and Endocrinology 2021 · PMID 34425083
  • Muller TD, et al. Anti-obesity drug discovery: advances and challenges. Nature Reviews Drug Discovery 2022 · PMID 34815532

Ecnoglutide safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Medullary thyroid carcinoma or MEN2 in the family.
  • A history of pancreatitis.
  • Type 1 diabetes, or insulin use that leaves low blood sugar unmanaged.
  • Gastroparesis.
  • Pregnancy, or planning one while appetite is suppressed.

What’s expected

  • GI effects dominate the trial tolerability tables, mostly mild to moderate.
  • Weight loss and better glucose control from a cAMP-biased GLP-1 signal.
  • Appetite quietening with early fullness.

Watch for

  • Persistent vomiting.
  • Pain high in the abdomen that moves to the back.
  • Hoarseness or a neck lump.

Labs that tell you it’s working

  • HbA1c: the main efficacy marker in the China phase 3 trials.
  • Lipase: the pancreatic safety check.
  • Comprehensive Metabolic Panel: dehydration shows in sodium, creatinine and glucose.
  • Insulin (Fasting): insulin sensitivity should improve with weight loss.

Long-acting cAMP-biased GLP-1 analog favoring cAMP over beta-arrestin signaling; approved in China, so trial safety data exist. PMID 39333121 PMID 40555243 PMID 42412371

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

A panel picked from how it works and what it can move: the tests, and why each is on it.

9 tests in one order
Marek Diagnostics · no doctor’s visit
Code CAMERON
Order this panel

Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.

The Metabolic Health & Prediabetes panel, explained

Ecnoglutide FAQ4 common questions

Is Ecnoglutide approved for human use?
No. Ecnoglutide is a research compound.
What is Ecnoglutide researched for?
Fat oxidation, appetite and energy regulation, insulin sensitivity and endurance capacity.
Which labs show whether it's doing anything?
HbA1c; Lipase; Comprehensive Metabolic Panel; Insulin: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Ecnoglutide: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Ecnoglutide is. Skool covers how it is run.

Free on this page

What Ecnoglutide is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Ecnoglutide is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Join Skool for the protocol